Editorial: Learning and doing: Operational research and access to HIV treatment in Africa

AIDS

Volumn 24, Issue SUPPL. 1, 2010, Pages

  Katzenstein, David ^a   Koulla Shiro, Sinata ^b,c,d   Laga, Marie ^e   Moatti, Jean Paul ^f,g,h  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Ministry of Public Health Division of Health Operations Research   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d Coordinator of the ANRS Research Site ^*  (Cameroon)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f AIX MARSEILLE UNIV   (France)

^g AIX MARSEILLE UNIVERSITY   (France)

^h OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DISEASE SURVEILLANCE; EDITORIAL; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; PUBLIC HEALTH; SCALE UP; SOUTH AFRICA; STIGMA; WORLD HEALTH ORGANIZATION; AFRICA; DISEASE MANAGEMENT; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH SERVICE; STANDARD;

AFRICA; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; RESEARCH SUPPORT AS TOPIC;

EID: 74249085417     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000366077.37827.0a     Document Type: Editorial

References (24)

1. United Nations General Assembly Special Session (UNGASS). Declaration of Commitment on HIV/AIDS, 25-27 June 2001, United Nations, New-York.
2. Katzenstein D, Laga M, Moatti JP. The evaluation of the HIV/ AIDS Drug Access Initiatives in Cote D'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS 2003; 17:S1-S4.
3. WHO/UNICEF/, UNAIDS. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva, 2009.
4. Mermin J, Were W, Ekwaru JP, Moore D, Downing R, Behumbiize P, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 2008; 371:752-759.
5. Bussmann H, Wester CW, Ndwapi N, Grundmann N, Gaolathe T, Puvimanasinghe J, et al. Five-year outcomes of initial patients treated in Botswana's national antiretroviral treatment program. AIDS 2008; 22:2303-2311.
6. Bendavid E, Bhattacharya J. The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes. Ann Intern Med 2009; 150:688-695.
7. Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, et al. Antiretroviral therapy and early mortality in South Africa. Bull WHO 2008; 86:678-687.
8. SouthAfrica.info. Zuma takes lead against HIV/Aids-http//: www.southafrica.info/about/health/aidsday-2009.htm
9. UNAIDS/WHO. 09 AIDS epidemic outlook. Geneva, 2009.
10. World Health Organization Maximizing Positive Synergies Collaborative Group (MPSCG). An assessment of interactions between global health initiatives and country health systems. Lancet 2009; 373: 2137-2169
11. Theobald S, Taegtmeyer M, Squire SB, Crichton J, Nhlema-Simwaka B, Thomson R, et al. Towards building equitable health systems in Sub-Saharan Africa: lessons from case studies on operational research. Health Res Policy Syst 2009; 7(1):26. [Epub ahead of print].
12. Holmes CB, Williams-Sherlock MA, Bouey PD. Monitoring and evaluation of PEPFAR treatment programmes. Lancet 2009; 374:1146-1147.
13. Peersman G, Rugg D, Erkkola T, Kiwango E, Yang J. Are the investments in national HIV monitoring and evaluation systems paying off? J Acquir Immune Defic Syndr 2009; 52 (Suppl 2): S87-S96.
14. DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 2009; Dec 9 [Epub ahead of print].
15. Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, et al. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clin Infect Dis 2009; 48 (9):1318-1322.
16. World Health Organization (WHO). Global Price Reporting Mechanism. 2009 Update. http://www.who.int/hiv/amds/gprm/ en/index.html
17. WHO/PEPFAR/UNAIDS. Treat, Train and Retain. Task shifting global recommendations and guidelines. Geneva, 2008. http:// www.who.int/healthsystems/ TTR-TaskShifting.pdf.
18. Atun R, Dybul M, Evans T, Kim JY, Moatti JP, Nishtar S, Russell A. Venice Statement on global health initiatives and health systems. Lancet 2009; 374:783-784.
19. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, et al.; on behalf of the Jinja trial team. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009; Nov 23. [Epub ahead of print].
20. Crowley S, Rollins N, Shaffer N, Guerma T, Vitoria M, Lo YR. New WHO HIV treatment and prevention guidelines. Lancet 2009 Nov 30. [Epub ahead of print].
21. Van Damme W, Kober K, Laga M. The real challenges for scaling up ART in sub-Saharan Africa. AIDS 2006; 20:653-656.
22. Ndembi N, Goodall RL, Dunn DT, McCormick A, Burke A, Lyagoba F, et al. Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir. J Infect Dis 2009; Nov 25. [Epub ahead of print].
23. Global Fund against AIDS, TB & Malaria (GFATM). Report of the Executive Director. Twentieth Board Meeting, Addis Ababa, Ethiopia 9-11 November 2009.
24. Walensky RP, Kuritzkes DR. The Impact of The President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and Why It Remains Essential. Clin Infect Dis 2009; Nov 30. [Epub ahead of print].